AR023657A1 - COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT - Google Patents

COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT

Info

Publication number
AR023657A1
AR023657A1 ARP990104627A ARP990104627A AR023657A1 AR 023657 A1 AR023657 A1 AR 023657A1 AR P990104627 A ARP990104627 A AR P990104627A AR P990104627 A ARP990104627 A AR P990104627A AR 023657 A1 AR023657 A1 AR 023657A1
Authority
AR
Argentina
Prior art keywords
composition
preparation
kit
same
pharmaceutical formulation
Prior art date
Application number
ARP990104627A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023657A1 publication Critical patent/AR023657A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Composicion que comprende un primer componente (a) que es (R)-3-N,N-diciclorobutilamino-8-fluor-3,4-dihidro-2H-1-benzopiran-5-carboxamida hidrogeno (2R,3R)-tartrato monohidrato y a un segundo componente (b) que es 1[3-(dimetilamino)propil]-1-(p-fluorfenil)-5-ftalancarbonitrilo, como racemato o enantiomero delmismo, en forma de base libre, o de sal farmacéuticamente aceptable y/o solvato del mismo, proceso de preparacion de la misma, formulaciones farmacéuticas quecontienen dicha composicion, usode dicha composicion para la preparacion de medicamentos utiles para el tratamiento de trastornos afectivos, tales comotrastornos del estado de ánimo y trastornos de la ansiedad con dicha composicion y un kit que contiene dicha composicion.Composition comprising a first component (a) which is (R) -3-N, N-dichlorobutylamino-8-fluor-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R, 3R) -tartrate monohydrate and a second component (b) which is 1 [3- (dimethylamino) propyl] -1- (p-fluorophenyl) -5-phthalancarbonitrile, as racemate or enantiomer thereof, as a free base, or pharmaceutically acceptable salt and / or solvate thereof, preparation process thereof, pharmaceutical formulations containing said composition, use of said composition for the preparation of useful medicines for the treatment of affective disorders, such as mood disorders and anxiety disorders with said composition and a kit containing said composition.

ARP990104627A 1998-09-16 1999-09-15 COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT AR023657A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (en) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
AR023657A1 true AR023657A1 (en) 2002-09-04

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104627A AR023657A1 (en) 1998-09-16 1999-09-15 COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT

Country Status (21)

Country Link
EP (1) EP1121119A1 (en)
JP (1) JP2002524509A (en)
KR (1) KR20010099648A (en)
CN (1) CN1317963A (en)
AR (1) AR023657A1 (en)
AU (1) AU6378199A (en)
BR (1) BR9913765A (en)
CA (1) CA2342585A1 (en)
CZ (1) CZ2001962A3 (en)
EE (1) EE200100156A (en)
HU (1) HUP0103569A3 (en)
ID (1) ID28359A (en)
IL (1) IL141520A0 (en)
IS (1) IS5877A (en)
NO (1) NO20011313L (en)
PL (1) PL346769A1 (en)
SE (1) SE9803157D0 (en)
SK (1) SK3272001A3 (en)
TR (1) TR200100769T2 (en)
WO (1) WO2000015219A1 (en)
ZA (1) ZA200101951B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (en) 1999-07-08 2002-06-12 Lundbeck & Co As H TREATMENT OF NEUROTIC DISORDERS
NZ524202A (en) 2000-10-13 2004-08-27 Neurosearch As Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
EP1901714A2 (en) 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (en) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
IL141520A0 (en) 2002-03-10
ID28359A (en) 2001-05-17
KR20010099648A (en) 2001-11-09
PL346769A1 (en) 2002-02-25
AU6378199A (en) 2000-04-03
TR200100769T2 (en) 2001-11-21
JP2002524509A (en) 2002-08-06
EE200100156A (en) 2002-08-15
EP1121119A1 (en) 2001-08-08
HUP0103569A3 (en) 2002-03-28
CN1317963A (en) 2001-10-17
WO2000015219A1 (en) 2000-03-23
SK3272001A3 (en) 2001-09-11
HUP0103569A2 (en) 2002-02-28
CZ2001962A3 (en) 2001-08-15
IS5877A (en) 2001-03-05
SE9803157D0 (en) 1998-09-16
ZA200101951B (en) 2002-06-10
NO20011313D0 (en) 2001-03-15
BR9913765A (en) 2001-06-05
NO20011313L (en) 2001-05-16
CA2342585A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
SE9501567D0 (en) A new combination
CA2532859C (en) Use of rotigotine for the treatment of depression
AR015448A1 (en) COMBINATION OF A 5-HT REABSORTION INHIBITOR WITH AN H5-HT1B ANTIGONIST OR PARTIAL AGONIST, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATION CONTAINING IT, ITS USE TO PREPARE MEDICINES TO TREAT KITTEN
KR980000447A (en) Pharmaceutical composition consisting of mirtazapine and one or more selective serotonin reuse inhibitors
MXPA05004381A (en) STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF.
ES2653852T3 (en) Pharmaceutical compositions containing dopamine receptor ligands and treatment procedures using dopamine receptor ligands
RU97119427A (en) COMBINATION OF 5-NT ACCELERATION INHIBITOR WITH THE 5-NTIA SELECTIVE ANTAGONIST
BR9810773A (en) Use of a long-acting local anesthetic ingredient, pharmaceutical composition, use of a local anesthetic, and, kit
BR0308133A (en) Crystalline polymorphic form of irinotecan hydrochloride
UY29823A1 (en) SUBSTITUTED DERIVATIVES OF 7-CHLORINE-3H-IMIDAZOL- (4,5-B) PIRIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
US20120046302A1 (en) Methods of treating cns disorders
CL2009000980A1 (en) Use of (s) -n- (2- (1,6,8-tetrahydro-2h-inden [5,4-b] furan-8-yl) ethyl] propionamide in combination with one or more drugs selected from a group defined to prepare a drug useful for the prevention or treatment of depression or anxiety disorders (divisional application 749-2006).
BRPI0713733A2 (en) methods to lessen symptoms of depression and to treat one or more psychological conditions, pharmaceutical composition and kit
BR0315346A (en) Method for the treatment or prevention of vasomotor symptoms in a patient, pharmaceutical formulation and use of norepinephrine reuptake inhibitor in combination with 5-h2a antagonist
AR023657A1 (en) COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT
CR7271A (en) NEW MELATONIN-BASED PHARMACEUTICAL FORMULATIONS AND SIMILAR COMPOUNDS FOR USE IN SOUND DISORDERS
SE9702066D0 (en) A new salt
SE9804126D0 (en) New pharmaceutical composition
AR033779A1 (en) USEFUL COMPOUNDS IN REFLUX DISEASE
CA2731660A1 (en) 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
CA2722763A1 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
BRPI0407529A (en) use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
AR021808A1 (en) NEW COMPOSITION
BRPI0407569A (en) use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
ES2362926T3 (en) NEW COMBINATION OF DRUGS AS AN ANTIDEPRESSIVE.